Commodities tumble while pharma stocks rise

Both base and precious metals have sold off today as the pessimism over struggling demand intensifies.

Source: Bloomberg

The appeal of mining companies has become increasingly difficult to see, as increasing production levels coupled with dwindling demand has given little reason to believe a bounce in the sector will soon materialise.

The performance of oil today would suggest that regardless of how uncomfortable OPEC members might be with the current oversupply to the markets, change is not anticipated.

Saudi Arabia looks unwilling to change from this current template and today’s oil inventories oversupply has just given fresh impetus to the bears ahead of OPEC’s Vienna meeting. The writing has been on the  wall for some time and overnight the decision will be made on Meggitt, G4S and Morrison’s eligibility to stay in the FTSE 100.

The pharmaceutical sector has done its best to drag the FTSE higher with Shire, GlaxoSmithKline and AstraZeneca making up the bulk of the best performing equities.

As successful as European Central Bank president Mario Draghi may have been in talking down the euro, his sheer will power alone has failed to prevent the eurozone inflation picture from becoming even worse.

The ADP employment date has never been the most reliable indicator ahead of Friday’s non-farm payrolls but the better-than-expected figures, along with the improved revision from the previous month, has given fresh power to GBP/USD as today’s moves have seen it smash through the psychological $1.500 barrier with consummate ease.

With Federal Reserve chair Janet Yellen yet to talk and the latest Fed Beige book due for release tonight, the selloff could still see lower lows.

IGA, may distribute information/research produced by its respective foreign marketing partners within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.

This information/research prepared by IGA or IGA Group is intended for general circulation. It does not take into account the specific investment objectives, financial situation or particular needs of any particular person. You should take into account your specific investment objectives, financial situation or particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. In addition to the disclaimer above, the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.

See important Research Disclaimer.